Methodological quality of meta-analyses on treatments for chronic obstructive pulmonary disease: a cross-sectional study using the AMSTAR (Assessing the Methodological Quality of Systematic Reviews) tool

Ref ID 111
First Author R. S. Ho
Journal NPJ PRIMARY CARE RESPIRATORY MEDICINE
Year Of Publishing 2015
URL https://pubmed.ncbi.nlm.nih.gov/25569783/
Keywords • Risk of bias
• Language
• Publication bias
• Pulmonology
• Transparency
• Low methodological quality
Problem(s) • Conflict of interest statement or disclosures for review authors missing
• Funding or sponsor of systematic review not reported
• Low methodological (AMSTAR) quality
• Limited quality assessment or no risk of bias
• Conflicts of interest or funding of included studies not assessed
• Language restriction
• Selective reporting of harms / safety / adverse events / side effects
• Poor consideration of publication bias
• Lack of statistical expertise in handling of quantitative data
Article Type Empirical
Article Subtype Cross-sectional survey/Methodological systematic review
First Author Country Hong Kong
Checklists • AMSTAR 1
Aim To assess the methodological quality of systematic reviews of chronic obstructive pulmonary disease published in the Cochrane Database and the Database of Abstracts of Systematic Reviews between 2000 to 2013.
Level of Investigation Descriptive
Summary of Findings Only 18% of the 79 included systematic reviews considered the scientific quality of primary studies when formulating conclusions and 49% used appropriate meta-analytic methods to combine findings. The problems were particularly acute among MAs on pharmacological treatments. In 48% of systematic reviews the authors did not report conflict of interest. Fifty-eight percent reported harmful effects of treatment. Publication bias was not assessed in 65% of systematic reviews, and only 10% had searched non-English databases.
Number of systematic reviews included 79
Number of eligible systematic reviews assessed 137